15th Jun 2009 17:06
15 June 2009
REGEN THERAPEUTICS PLC
("ReGen" or the "Company"; Ticker: (RGT))
TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES
Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
ReGen Therapeutics Plc
2. Reason for the notification:
An event changing the breakdown of voting rights
3. Full name of person(s) subject to the notification obligation (iii):
Andrew Clement Wilson
4. Full name of shareholder(s) (if difference from 3):
As Above
5. Date of the transaction and date on which the threshold is crossed or reached (v):
9th June 2009
6. Date on which issued notified:
12th June 2009
7. Threshold(s) that is/are crossed or reached:
10% to 9%
8. Notified details
A: Voting rights attached to shares
Class/type of share if possible using the ISIN Code GB00B28XMY25
Situation Previous to the triggering transaction (vi) -
Number of Shares 2,591,250
Number of Voting Rights (viii) 2,591,250
Resulting situation after the triggering transaction (viii) -
Number of Shares 2,591,750
Number of Voting Rights - Direct (x) 2,591,750
Number of Voting Rights - Indirect (xi) N/A
% of voting rights - Direct 9.76917%
% of voting rights - Indirect N/A
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of financial instrument N/A
Expiration date (xiii) N/A
Exercise/Conversion Period/Date (xiv) N/A
Number of voting rights that may be acquired if the
instrument is exercised/converted N/A
% of voting rights N/A
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument N/A
Exercise Price N/A
Experation Date N/A
Number of voting rights
Instrument refers to N/A
% of voting rights N/A
Total (A+B+C)
Number of voting rights 2,591,750
% of voting rights 9.76917 %
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):
Giltspur Nominees Ltd
Brewin Dolphin
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information: Brewin Dolphin As
Broker
14. Contact name: Stephen Cartwright
15. Contact telephone number: 02890446000
For further information:
For further information, please contact: Percy Lomax ReGen Therapeutics Plc Tel: 020 7153 4920 Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel: 020 7628 3396
Related Shares:
TILS.L